- Home
- RKDA vs APVO Comparison
RKDA vs APVO Comparison
Compare RKDA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKDA
- APVO
- Stock Information
- Founded
- RKDA 2002
- APVO 2016
- Country
- RKDA United States
- APVO United States
- Employees
- RKDA N/A
- APVO N/A
- Industry
- RKDA Agricultural Chemicals
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- RKDA Industrials
- APVO Health Care
- Exchange
- RKDA Nasdaq
- APVO Nasdaq
- Market Cap
- RKDA 5.3M
- APVO 4.1M
- IPO Year
- RKDA 2015
- APVO N/A
- Fundamental
- Price
- RKDA $4.78
- APVO $3.00
- Analyst Decision
- RKDA Strong Buy
- APVO Strong Buy
- Analyst Count
- RKDA 1
- APVO 1
- Target Price
- RKDA $6.00
- APVO $5,920.00
- AVG Volume (30 Days)
- RKDA 18.4K
- APVO 6.7M
- Earning Date
- RKDA 08-12-2025
- APVO 08-07-2025
- Dividend Yield
- RKDA N/A
- APVO N/A
- EPS Growth
- RKDA N/A
- APVO N/A
- EPS
- RKDA N/A
- APVO N/A
- Revenue
- RKDA $5,258,000.00
- APVO N/A
- Revenue This Year
- RKDA $29.40
- APVO N/A
- Revenue Next Year
- RKDA $25.00
- APVO N/A
- P/E Ratio
- RKDA N/A
- APVO N/A
- Revenue Growth
- RKDA 24.92
- APVO N/A
- 52 Week Low
- RKDA $2.40
- APVO $2.81
- 52 Week High
- RKDA $10.31
- APVO $485.37
- Technical
- Relative Strength Index (RSI)
- RKDA 57.58
- APVO 34.83
- Support Level
- RKDA $4.49
- APVO $2.89
- Resistance Level
- RKDA $4.86
- APVO $3.20
- Average True Range (ATR)
- RKDA 0.37
- APVO 0.27
- MACD
- RKDA 0.01
- APVO 0.24
- Stochastic Oscillator
- RKDA 61.32
- APVO 10.63
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.